The 7th All-hands meeting of INSIST was again held in person for a large part of the consortium, on November 16-17, 2021, in Geneva. Those people that were to far away or for other reasons not able to travel joined us online. As we are nearing the end of INSIST, it was very useful to be able to discuss face-to-face again. 

Groepsfoto

We had two invited speakers with very interesting talks;

Kylian Treurniet  on the NO-IV trial/IRIS en aspiration versus stent retriever in NO-IV 

And Paolo Machi on in vitro work with different stent retrievers

For the  agenda, read on. 

 

 

 

Program 7th INSIST All-hands Meeting

Date: November 16-17th 2021

Venue: Geneva

Tuesday, Nov 16th 2021

 

Time

Title

Speakers

8:45-9:15

NO-IV trial/IRIS en aspiration versus stent retriever in NO-IV (including discussion)

Kilian Treurniet

9.15-10:00

WP6: Integration and validation

Claire

10:00-10:30

Discussion

All

10:30-10:45

Break

 

10:45-11:15

WP 2: Population and Morphology Models.

Hester

11:15-11:30

Discussion

All

11:30-12:30

WP 3: In Silico Models for thrombosis and thrombolysis.

Bastien

12:30-12:45

Discussion

All

12:45-13:45

Lunch

 

13:45-14:30

WP 4: In Silico Models for Thrombectomy.

Patrick

14:30-14:45

Discussion

All

14:45-15:30

WP 5: In Silico Models for Perfusion Defects and Tissue Damage.

Stephen/Tamas

15:30-15:45

Discussion

All

15:45-16:00

Break

 

16:00-16:45

Invited speaker Paolo Machi (on in vitro work with different stent retrievers)

(incl 15 min. discussion)

16:45-17:30

General assembly meeting

All Beneficiaries

19:00

Dinner

Wednesday, Nov 17th 2021

Time

Title

Speakers

9:00-10:45

  • Continued discussion on validation data for module II (All WPs)
  • Discussion on which trials to run, suggestion:
  • MRCLEAN trial
  • Stent retriever comparison trial
  • MRCLEAN NO-IV trial

·       Using a statistical model to generate infarct distribution maps as an alternative to the physical models to quantify the benefit of the physical models (relevant to task 6.5?)

·       WP3/WP6(/WP2?): what are the next steps given the current thrombolysis model in WP6 is not giving physiologically reasonable results with the updated fibrin concentration

·       Thrombectomy: stent retriever positioning and virtual population linkage

·       Blood flow/perfusion: ongoing issues with coupled vs decoupled results in the trial

·       ask 6.5

·       What aspects of stroke are we not capturing in the models?

·       …

All

10:45-11:00

Break

 

11:00-12:00

Continuation of the discussion above

 

12:00-12:30

WP7 Dissemination and exploitation

-          Focus group meetings

-          Two/three workshops (1.5 day) during the 3rd and 4th year of the project targeting stroke clinicians and scientists

-          Two innovation events

-          Two hands-on demonstrations

All

12:30-13:30

Lunch